Ketoralac
Ketoralac Brand names, Ketoralac Analogs
Ketoralac Brand Names Mixture
- No information avaliable
Ketoralac Chemical_Formula
C17H11N5
Ketoralac RX_link
http://www.rxlist.com/cgi/generic2/letroz.htm
Ketoralac fda sheet
Ketoralac msds (material safety sheet)
Ketoralac Synthesis Reference
No information avaliable
Ketoralac Molecular Weight
285.303 g/mol
Ketoralac Melting Point
184-185 oC
Ketoralac H2O Solubility
No information avaliable
Ketoralac State
Solid
Ketoralac LogP
3.385
Ketoralac Dosage Forms
Tablet
Ketoralac Indication
For the extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy. Also for first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. Also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Ketoralac Pharmacology
Letrozole is an aromatase inhibitor used in the treatment of breast cancer. Aromatase inhibitors work by inhibiting the action of the enzyme aromatase, which converts androgens into estrogens by a process called aromatization. As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue.
Ketoralac Absorption
Rapidly and completely absorbed. Absorption is not affected by food.
Ketoralac side effects and Toxicity
No information avaliable
Ketoralac Patient Information
No information avaliable
Ketoralac Organisms Affected
Humans and other mammals
